Theralase Technologies

About:

Theralase Technologies is a biopharmaceutical company

Website: http://theralase.com/

Description:

Theralase Technologies is a biopharmaceutical company focused on the design, development, manufacturing, and sale of patented laser technology platforms used in a wide range of bio-stimulative and bio-destructive clinical applications in patients. Theralase’s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the research and development of laser-based technologies for the destruction of cancer cells and other disease states. The Therapeutic Laser Technology division is focused on the development and commercialization of laser-based non-invasive therapeutic devices to eliminate pain, reduce inflammation, and accelerate tissue healing. The Photo Dynamic Therapy division is focused on the discovery and development of small, light-activated molecules and companion laser systems that activate them with high anti-cancer effectiveness, microbial sterilization potency, and bacterial infection control.

Total Funding Amount:

$22.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

1994-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2024-09-24

IPO Status:

Public

Industries:

© 2025 bioDAO.ai